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 Estimation of ventricular contractility and ventricular arterial coupling is clinically important in 
diagnosing and treating cardiac dysfunction in the critically ill. However, experimental assessment of 
indexes of ventricular contractility, such as the end-systolic pressure-volume relationship, requires a 
highly invasive manoeuvre and measurements that are not typical in an intensive care unit (ICU). This 
research describes the use of a previously validated cardiovascular system model and parameter 
identification process to evaluate the right ventricular arterial coupling in septic shock. Model-based 
ventricular arterial coupling is defined by the ratio of the end systolic right ventricular elastance (𝐸!"#$%) 
over the pulmonary artery elastance (𝐸!") or the mean pulmonary inflow resistance (Rpulin). Results are 
compared to the clinical gold-standard assessment (conductance catheter method). Six anesthetized 
healthy pigs weighing 20–30 kg received a 0.5 mg kg−1 endotoxin infusion over a period of 30 min from 
T0 to T30, to induce septic shock and veno-venous hemofiltration was used from T60 onward. The results 
show good agreement with the gold-standard experimental assessment. In particular, the model-based 
right ventricular elastance (𝐸!"#$%) correlates well with the clinical gold standard (R2 = 0.69) and the 
model-based non-invasive coupling (𝐸!"#$%/𝑅!"#$%) follow the same trends and dynamics (R2 = 0.37). 
The overall results show the potential to develop a model-based sensor to monitor ventricular-arterial 
coupling in clinical real-time. 







Blood flow creates a continuous interaction between the cardiac ventricle and the arterial tree. This 
interaction, known as ventriculo-arterial coupling, is the main determinant of stroke volume and ejection 
pressure because it relates effort or force capacity to output resistance or afterload. This concept, which 
can be applied to the systemic and pulmonary circulations, and was developed as a whole quantitative and 
structured theory by Sunagawa [1]. 
 
Theoretically, acute assessment of the ventriculo-arterial coupling should lead to optimal hemodynamic 
therapy [2]. The effect of the coupling is mainly seen in changes in ejection fraction and vascular 
resistances. However, these parameters do not completely characterize both ventricular contractility and 
cardiovascular energetics. Thus, it is clinically important to define an index reflecting the interaction 
between arterial and ventricular properties, to assess the adequacy of hemodynamic treatment.  
 
However, the technical difficulties of instantaneous pressure and volume measurements requiring high-
fidelity, manometer-tipped catheters and ultrasonic microcrystals or conductance catheters have hampered 
routine clinical applications due to cost and invasiveness. In addition, it has been generally assumed that 
the frequency response of the fluid-filled pressure catheters that are commonly used would be insufficient 
for instantaneous measurements, but would be acceptable for mean pressure estimations. Equally, given 
these additional invasive measurements, assessment of this coupling requires an additional vena cava 
occlusion manoeuvre which carries added risk. Hence, the goal of regularly measuring ventriculo-arterial 





Recently, mathematical models of the cardiovascular system (CVS) have been developed to assist 
medical professionals in differentiating and diagnosing CVS disturbances, such as pulmonary embolism 
[3], changes in positive end expiratory pressure (PEEP) [4, 5], the impact of inotrope therapy [6], and 
septic shock [7]. These CVS models are able to capture all the fundamental CVS pressure and volume 
values and trends when compared to measured experimental data. Importantly, they capture all clinically 
relevant trends that distinguish these disease states, hemodynamic disturbances and the impact of 
therapies. The goal is to use the models and readily available clinical measurements to enable non-
invasive patient specific monitoring and diagnosis.  
 
In particular, this study uses a CVS model and identification process [3-5, 7] to estimate right ventricular-
arterial coupling. This model-based approach offers a potentially reliable procedure to assess coupling 
without further invasive measurements or procedures. Equally importantly, it offers the potential to 
develop a model-based sensor to monitor this metric in clinical real-time turning readily available data 
into a clear, clinically relevant physiological picture. As such, it would offer significant benefit in 





2. MATERIALS AND METHODS 
 
All experimental procedures and protocols used in this investigation were reviewed and approved by the 
Ethics Committee of the Medical Faculty of the University of Liege. They were performed in accordance 
with the Guide for the Care and Use of Laboratory Animals as adopted and promulgated by the U.S. 
National Institutes of Health (NIH Publication No.85-23, revised 1996). The surgical preparation and 
experimental protocol are described in [8] with relevant details repeated here. 
 
2.1 Experimental protocol and physiological measurements 
Experiments were performed on 6 healthy pure pietran pigs of either sex weighing from 20 to 30kg. Data 
from 5 pigs was analysed and identified for this research because the measurements from one animal had 
to be omitted as they contained corrupted data. The animals were premedicated and anesthetized as 
described previously [8]. A micromanometer-tipped catheter (Sentron pressure-measuring catheter, 
Cordis, Miami, FL, U.S.A.) was inserted into the main pulmonary artery and a 14-mm diameter 
perivascular flow probe (Transonic Systems, Ithaca, NY, U.S.A.) was adjusted around the main 
pulmonary artery 2 cm downstream of the pulmonary valve. Left atrial pressure was measured with a 
micromanometer-tipped catheter and systemic blood pressure was monitored with a micromanometer-
tipped catheter inserted into the descending thoracic aorta through the left femoral artery. A 7F, 12-
electrode (8-mm interelectrode distance) conductance micromanometer-tipped catheter (CD Leycom, 
Zoetermeer, The Netherlands) was inserted through the right ventricle (RV) infundibulum into the right 
ventricle and positioned so that all electrodes were in the RV cavity. A 6F Fogarty balloon catheter 
(Baxter Healthcare Corp., Oakland, Calif) was advanced into the inferior vena cava through a right 




After a 30 min stabilization period, the animals received a 0.5mg/kg endotoxin infusion 
(Lipopolysaccharide from Escherichia Coli serotype 0127:B8; Sigma Chemical, St Louis, MO, USA) 
over a 30 min period (from T0 to T30). They underwent, from T60 onwards, a zero-balance continuous 
veno-venous hemofiltration (CVVH) at a rate of 45ml/kg/h. A 0.7m2 large pore (78 Å) membrane with a 
cutoff of 80kDa (Sureflux FH 70, Nipro, Osaka, Japan) and a hemofiltration device Baxter BM 25-BM 14 
(Baxter Health Care, Munich, Germany) were used. Ultrafiltrate was replaced in the postdilution mode by 
a bicarbonate-buffered hemofiltration fluid (Na+: 150mM, K+: 3mM, bicarbonate: 30mM) at a 
temperature of 37°C. 
 
Hemodynamic data included pulmonary artery pressure (PAP) wave, pulmonary blood flow wave, left 
atrial pressure, systemic arterial pressure, heart rate, RV pressure, RV volume and RV pressure-volume 
(PV) loops. These parameters were monitored online and recorded every 30 minutes from T0 to T240 
during a short apneic phase and stored for subsequent analysis. All analog signals were sampled at 200 
Hz and continuously converted to digital form with an appropriate system (Codas, DataQ Instruments 
Inc., Akron, OH, USA). 
 
2.2 Clinical assessment of ventricular properties 
Ventricular end-systolic elastance is the reference contractility parameter that characterizes ventricular 
systolic function. Clinically, it is defined by the slope of the ventricular end-systolic P-V relation 
(ESPVR). Experimentally, right ventricular PV loops were obtained using the conductance catheter 
method [9]. The RV end-systolic elastance (𝐸!"!"#) was then determined during a rapid inferior vena cava 
occlusion manoeuvre [10]. Preload was reduced by progressive inflation of the Fogarty balloon in the 
inferior vena cava for no more than 10s to avoid the intervention of a baroreflex mechanism. End-systolic 




invasiveness and risk, the ethical considerations of this gold-standard clinical assessment preclude its 
regular clinical use. 
2.3 Clinical assessment of arterial properties 
Calculation of  the arterial input impedance is accepted as being the most complete description of the 
hydraulic load faced by the ventricle [11]. This impedance is a complex number that can be estimated in 
the frequency domain using a windkessel model that is an electrical analogy of the vascular bed [12]. In 
this study, a four-element windkessel model (WK4) was used to analyze the flow conditions in the 
pulmonary circulation throughout the experimental process. In this model (Figure 1), a resistor (R2) 
represents the resistive properties of the pulmonary vasculature. A capacitor (C) is placed parallel to R2 
and describes the compliant properties of the pulmonary arterial tree. A second resistor (R1) is placed at 
the input of the circuit and reflects the characteristic impedance of the proximal pulmonary stem. Finally, 
an inductance (L) is added in series to accounts for the inertial properties of the blood. 
 
The windkessel model thus separates the calculation of every component of the input impedance 
(compliance, main and peripheral resistances) in the model. In the time domain, these elements can be 
combined to define an arterial elastance (𝐸!!"#), which reflects RV afterload [13]: 
 𝐸!!"# = 𝑅! + 𝑅! /[𝑇! + 𝑅!𝐶(1− 𝑒!!!/!!!)]  (1) 
 
where Ts and Td are respectively the systolic and diastolic intervals, while R1, R2 and C can be estimated 






Fig. 1. The four-elements windkessel model (WK4). R1 = resistance of the main vessels, R2 = peripheral 
resistance, C = compliance and L = inductance. 
 
2.4 Ventriculo-arterial coupling 
The 𝐸!"!"#/𝐸!!"# ratio, obtained from P-V relations, characterizes the ventriculo-arterial interaction and is 
known as the ventriculo-arterial coupling index [15]. The efficiency of energy transfers between the 
ventricle and the arterial system strongly depends on this ratio. Under normal conditions, the right 
ventricle operates at a maximum efficiency and a submaximal stroke work (𝐸!"!"#/𝐸!!"# > 1), while 
uncoupling occurs when  𝐸!"!"#/𝐸!!"# < 1 [16-18]. 
 
2.5 CVS Model 
The CVS model is a lumped parameter model of 6-8 elastic chambers with two active chambers for the 
left and right ventricles. The original model has been extended [3-7, 19, 20] and an overview of the 8 
chamber version used in this research is given in Figure 2. Each chamber is characterized by the flow in 
and out of the chamber, the pressure up- and downstream, the resistances of the heart valves, and inertia 





Fig. 2. Extended CVS model overview. 
 
The CVS model uses the classical concept of time varying elastance proposed by Suga et al. [21] to 
simulate the cardiac muscle activation. More specifically, the upper and lower limits of the elastance are 




relationship (EDPVR) [22]. Combining ESPVR and EDPVR yields an equation relating the ventricular 
pressure (P) to the ventricular volume (V): 
 𝑃 = 𝑒 𝑡 𝐸!"#$% 𝑉 − 𝑉! + 1− 𝑒 𝑡 𝑃!(𝑒! !!!! − 1) (3) 
 
where P0, V0 and λ are respectively, the pressure gradient and the volume at zero pressure and the 
curvature, while Eesrvf is the RV end-systolic elastance and e(t) is the generic activation function (Figure 
3) that accounts for ventricular activation [19, 20]. 
 
 
Fig. 3. Plot of the activation function e(t). 
The pulmonary artery is also described by a simple passive pressure-volume relationship: 
 𝑃!! = 𝐸!"𝑉!" (4) 
 
where Ppa and Vpa denote the pulmonary artery pressure and volume respectively. Epa is the arterial 





A full list of the model equations and parameters is given in the appendix and further details can be found 
in references [3-7, 23-27]. 
 
2.5  Model-based assessment of 𝐸!"#$%/𝐸!"      - Integral-based model identification  
The parameter identification method used in this research has already been shown to rapidly and 
accurately identify virtually the entire model parameter set in the presence of significant measurement 
noise and limited measurements [25]. It has been successfully tested on experimental animal models of 
pulmonary embolism [3], PEEP titrations and volume therapy decision support [4, 5], and septic shock 
experiments [7].  
 
During the identification process only the systolic and diastolic values of both ventricular volumes, the 
pressures in the aorta (Pao) and in the pulmonary artery (Ppa) are used. It is important to note that in this 
study, it was not intended to perfectly match the pressure and volume waveform shapes, but only the 
minimum (diastolic) and maximum (systolic) values. Hence, it seeks to capture the primary, clinically 
relevant dynamics for decision support at the bedside, rather than a potentially more perfect physiological 
picture.  
 
In this model-based approach, the elastance defined in Equation 2 (𝐸!"#$%) is directly identified from the 
experimental data using the model and the identification method. The arterial compliance (Cpa) and 
consequently the arterial elastance (Epa) in Equation 4 is evaluated from experimental data with the 





𝐸!" = 1/𝐶!" = 𝑃𝑃!𝑆𝑉  (5) 
 
where PPa denotes the artery pulse pressure and SV the stroke volume.  
 
The arterial elastance from the windkessel model (𝐸!!"#) reflects the afterload. In the CVS model, two 
parameters may capture this effect. First, Epa defined in Equation 5. However, truer to the physiological 
situation, the mean pulmonary inflow resistance (Rpulin) calculated during the model-based identification 
process, captures this effect as well [30, 31]. More importantly, because it is identified directly from the 
data, it should better represent the afterload for each subject compared to the generic approximation in 
Equation 5. 
 
Hence, this study examines two non-invasive model-based measures for the clinically assessed 
ventriculo-arterial coupling index 𝐸!"!"#/𝐸!!"#, comparing both 𝐸!"#$%/𝐸!"   and 𝐸!"#$%/𝑅!"#$%. The goal 
is to obtain a non-invasive model-based measure that best captures the highly invasive and complex gold-
standard clinical assessment, and is also physiologically representative and relevant.  
 
The identification process is made every 30 minutes through the induced septic shock and hemofiltration. 
A value is identified at each point to assess these metrics. Thus, the ability of the model-based metrics to 






Figure 4 shows the mean (model-based) right ventricle end-systolic elastance (𝐸!"#$%) over all pigs during 
the experiment. This elastance is calculated during the model identification process and the value depends 
on the assumed volume at zero pressure (V0) for the ventricle used in the model. For reasons of simplicity, 
this value is assumed to be zero (V0 =0 ml) during the identification. However, 𝐸!"#$% can easily be 
adjusted for a different, and potentially more realistic, V0, as seen in Figure 4, where 𝐸!"#$% is depicted for 
V0 =0 ml and V0 =23 ml. These V0 values span a realistic range [32].  
 
 






These identified 𝐸!"#$% values (at V0 = 0ml) are compared with previously reported clinically assessed 
values [8]. Figure 5 shows that the values and the resulting correlation trends match well (R2 = 0.69) with 
a trend line defined:  𝐸!"!"# = 0.22 ∗ 𝐸!"#$% + 0.45. This line does not pass through the origin probably 
due to experimental errors on   𝐸!"!"# and no pig-specific identification of V0 from the data. 
 
Fig. 5. Experimental vs simulated elastance for all 5 analysed pigs during the endotoxic shock 
experiment. The stars correspond to the mean measurements at each measurement time. 
 
To compare the right ventricular-arterial coupling, we computed the first model identified coupling index 𝐸!"#$%/𝐸!"  . Even if the simulated and experimentally derived elastances match accurately, as seen in 
Figure 5, a very poor correlation is found for the coupling ratio (R2 = 0.04).  
 
This correlation is much better using 𝐸!"#$%/𝑅!"#$% (R2 = 0.37), as shown in Figure 6. Figure 7 shows the 






Fig. 6. Experimental coupling vs simulated coupling with Rpulin for all 5 analysed pigs during the 
endotoxic shock experiment. The stars correspond to the mean measurements at each measurement time. 
 
 





Figure 8 presents the RV-vascular coupling using 𝐸!"#$%/𝑅!"#$% during the endotoxic shock experiment 
as a further marker of the impact of sepsis. It shows the improved correlation between the new identified 
coupling metric and the experimental coupling. The overall trends over time, beginning with a sharp fall 
to a value approaching 1.0 and uncoupling, followed by a recovery due to hemofiltration treatment. 
 
 
Figure 8:  Mean experimental ( 𝐸!"!"#/𝐸!!"#) and identified (𝐸!"#$%/𝑅!"#$%)  right ventricular-arterial 







The major findings of this research are twofold. First, the clinical results obtained previously [8] are 
matched using a model-based metric that requires no invasive manoeuvres or added measurements. In 
Figure 8 it can be seen how hemofiltration, which starts at 60 min into the experiment, is able to prevent 
RV-vascular uncoupling (ratio < 1.0). This effect or behaviour is commonly observed during the late 
phases of endotoxic shock [33], and is accurately captured by the CVS model. 
 
In particular, the data shows that in the early phases of endotoxic shock, RV-vascular coupling is 
preserved by an increase in RV contractility (𝐸!"#$%) as seen in Figure 4. During the later stages and with 
CVVH, RV-vascular coupling is preserved where a decrease in pulmonary vascular resistance (Rpulin), as 
seen in Figure 7, which is suggested to be the main reason for this result [8]. These results thus allow for 
a better understanding of the mechanisms of RV dysfunction during septic shock and thus have the 
potential to lead to more effective therapies and strategies for treating myocardial depression in septic 
shock. Equally, this clearer physiological picture is available from the model in clinical real-time. 
 
Second, the results of this research present an important clinical outcome. They show that it is possible to 
relatively accurately calculate the right ventricular-arterial coupling without the need of an invasive 
preload reduction by doing this model-based approach. As mentioned previously, the assessment of RV 
contractility requires the occlusion of the vena cava, which raises obvious ethical and medical concerns 
and is far too difficult to perform as part of regular clinical practice. This model-based approach uses only 
a clinically realistic and minimal data set, and uses no data from these occlusion manoeuvres. Hence, the 
results presented are clinically accurate and realistic for a (potentially) typical CVS monitoring scenario 





The RV end-systolic elastance is directly identified from the model and the available experimental data. 
Using only minimum and maximum values of arterial pressure and ventricular volume, the identification 
process gives an accurate measure of the elastance.  
 
Moreover, using the pulmonary resistance (Rpulin) to characterize the RV afterload, there is no need to 
evaluate the arterial elastance using the parameters of the windkessel model, which has the main 
drawback of needing accurate pressure and flow waveforms [34] usually obtained via added manoeuvres 
and/or extensive signal conditioning. Equally, the windkessel model has its own limitation in representing 
an active, regulated non-linear system by a linear model. In contrast, the overall CVS model is non-linear 
and may better captures these effects. 
 
Although a good correlation was found between the experimental and the model-based measures of the 
preload and the afterload, the resulting ratio assessing ventricular-arterial coupling using Epa shows a 
comparatively poor correlation of R2 = 0.04. As the coupling ratio is defined by the ratio of the preload to 
the afterload, there can be a propagation of experimental errors. However, defining the RV ventricular-
arterial coupling with the model-based Rpulin 
This outcome shows the importance of using subject-specific identified parameters instead of parameters 
estimated from the experimental data. Using Rpulin, a valid measure of afterload in the model context [25, 
30, 31], also means that the entire ventriculo-arterial coupling index is defined by the models as identified 
directly from the data, without general or population assumptions. Hence, better consistency is enforced, 
which, in this case, results in a better result with this validated model. 
 
Overall, this model-based approach thus offers potentially a new and more reliable procedure to assess 
the right ventricle contractility, as well as the right ventricular-arterial coupling. It also defines a new 




clinical real-time and thus be used to guide therapy. In particular, because every element of this new 
metric is available at the bedside and can be assessed effectively continuously, it is a metric that can be 
used at any point in time the clinician wishes to assess, diagnose, and monitor patient condition, without 
added invasive measurements or manoeuvres. 
 
 
5.  CONCLUSIONS 
This study shows the ability of a clinically validated CVS model to adequately and realistically capture 
the impact of pressure-volume changes during endotoxic shock and its treatment with CVVH. 
Comparable results to clinical experimental metrics that are not available at the (typical) ICU bedside for 
both values and clinical trends are obtained for the RV-vascular coupling. This research thus increases 
confidence in the clinical applicability and validity of this overall model-based diagnostic monitoring 
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The model is defined by Equations (A1) – (A29). A full list of the model parameters and outputs are 
described in Table A1 and A2. 
sptlvlvf VVV −=  (A1) 
sptrvrvf VVV +=  (A2) 
avavaolvavav RQPPQL −−=  (A3) 
mtmtlvpumtmt RQPPQL −−=  (A4) 
pvpvparvpvpv RQPPQL −−=  (A5) 
tctcrvvctctc RQPPQL −−=  (A6) 
( ) thpudpupupu PVVEP +−= ,  (A7) 
( ) thpadpapapa PVVEP +−= ,  (A8) 
( ) thvcdvcvcvc PVVEP +−= ,  (A9) 
( )aodaoaoao VVEP ,−=  (A10) 
( )sysdsyssyssys VVEP ,−=  (A11) 
( )capdcapcapcap VVEP ,−=  (A12) 
mtpuloutpv QQV −=  (A13) 
pulinpvpa QQV −=  (A14) 
tcvrvc QQV −=  (A15) 
sysavao QQV −=  (A16) 
vrsyssys QQV −=  (A17) 





















=  (A21) 
perilvflv PPP +=  (A22) 
perirvfrv PPP +=  (A23) 
( ) ( ) ( )( )11 ,0,0,, −⋅⋅−+−⋅⋅= − lvflvflvf VVlvflvfdlvflvfeslvf ePdriLVVEdriLP λ  (A24) 
( ) ( ) ( )( )11 ,0,0,, −⋅⋅−+−⋅⋅= − rvfrvfrvf VVrvfrvfdrvfrvfesrvf ePdriRVVEdriRP λ  (A25) 
( ) ( ) ( ) ( )( )
( ) ( ) ( )( ) ( )( ) ( ) ( )


































( )( )1,0,0 −= − pcdpcdpcd VVpcdpcd ePP λ  (A28) 









Table A1: CVS model parameters 
 
Symbol Description 
Ees,lv Left ventricle end systolic elastance 
Eao Aortic elastance 
Evc Vena cava elastance 
Ees,rvf Right ventricle end systolic elastance 
Epa Pulmonary artery elastance 
Epu Pulmonary vein elastance 
Esys Systemic veins elastance 
Ecap Pulmonary capillaries elastance 
Rmt Mitral valve resistance 
Rav Aortic valve resistance 
Rsys Systemic vascular resistance 
Rtc Tricuspid resistance 
Rpv Pulmonary valve resistance 
Rpulin Pulmonary inflow resistance 
Rpulout Pulmonary outflow resistance 
Pvc Vena cava pressure 
Ppu Pulmonary vein pressure 
driL Left ventricle normalised time varying elastance 
driR Right ventricle normalised time varying elastance 
Vd,ao Aortic unstressed volume 
Vd,vc Vena cava unstressed volume 
Vd,pa Pulmonary artery unstressed volume 
Vd,pu Pulmonary vein unstressed volume 
Vd,sys Systemic veins unstressed volume 
Vd,cap Pulmonary capillaries unstressed volume 
Lmt Mitral valve inertance 
Lav Aortic valve inertance 
Ltc Tricuspid valve inertance 









Table A2: Outputs of the CVS model 
Symbol Description 
Vlv Left ventricle volume 
Vao Aorta volume 
Vvc Vena cava volume 
Vrv Right ventricle volume 
Vpa Pulmonary artery volume 
Vpu Pulmonary vein volume 
Vsys Systemic veins volume 
Vcap Pulmonary capillaries volume 
Plv Left ventricle pressure  
Pao Aorta pressure 
Pvc Vena cava pressure 
Prv Right ventricle pressure 
Ppa Pulmonary artery pressure 
Ppu Pulmonary vein pressure 
Psys Systemic veins pressure 
Pcap Pulmonary capillaries pressure 
Qmt Mitral valve flow rate 
Qav Aortic valve flow rate 
Qvr Venous return flow rate 
Qtc Tricuspid valve flow rate 
Qpv Pulmonary valve flow rate 
Qpulin Pulmonary inflow rate 
Qpulout Pulmonary outflow rate 
Vspt Septum volume 
Ppcd Pericardium pressure 
  
 
 
